Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Reitz colleagues start their own company
2014-07-01

The University of the Free State (UFS) and the five colleagues implicated in the Reitz incident of 2008 reached the final chapter in the reparation process in restoring the dignity of these colleagues on Thursday 19 June 2014.

Mr Mothibedi Molete and Mss Mankoe Naomi Phororo, Emmah Koko, Nkgapeng Adams and Sebuasengwe Mittah Ntlatseng, former cleaning staff at the UFS, are now the directors of their own cleaning company, Mamello Trading.

Furthering on its promise to assist the new-found company, the UFS has also appointed Mamello Trading as a service provider responsible for services at its South Campus.

It has been six years since the Reitz incident at the UFS and Dr Choice Makhetha, Vice-Rector: External Relations, described the journey of the past six years as a learning experience for all the stakeholders.

“This journey continues as there is still work to be done, but every milestone achieved, deserves a celebration like today’s,” Dr Makhetha said.

In 2010 the UFS signed a deed of settlement with the colleagues which committed the UFS to help them establish a cleaning company. This was followed by a reconciliation ceremony in 2011.

In 2012 the UFS assisted with the registration of the company Mamello Trading.

Dr Makhetha explained that in 2013 the UFS assisted in training the new directors and mentoring them for 12 months. 

Earlier this year, Mamello Trading signed a cleaning contract of four years with the UFS. Three of the directors’ daughters also received bursaries and are currently studying at the UFS.

Advocate Mohamed Ameermia, Commissioner at the Human Rights Commission, congratulated the management of the UFS on the reparation and reconciliation process they followed in restoring the dignity of the five colleagues.

The directors of Mamello Trading each had a special message of their journey and thanks. Their messages were as follows:

Rebecca Adams – After the video was exposed, I was hurt and was psychologically affected. By offering their apologies to us, the four students indicated that what they had done was a mistake. As a parent, when a child apologises you must accept that apology.
Emma Koko – I was shocked after the video was shown in public. I had a mother-child-like relationship with one of the students and that video tarnished my image as a human being. During the time of reconciliation these students showed remorse for what they had done.
David Molete – I was devastated, hurt and fearful to meet people. I ended up at a psychiatric hospital and attended counseling services which helped me to heal. The students apologised and I accepted because they were sincere.
Mittah Ntlaseng – The video impacted negatively on my dignity. The UFS assisted us with visits to psychologists. Now I feel I am a business owner and it is an opportunity for me to rebuild my self-esteem. 

Naomi Phororo – Mamello Trading is a business venture which is going to bring changes to our lives and families. The training I have received has enabled me to know how to manage the business.

 

Issued by: Lacea Loader (Director: Communication and Brand Management)
Telephone: +27(0)51 401 2584
Fax: +27(0)51 444 6393
E-mail: news@ufs.ac.za

  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept